chartexchange

SONN
Sonnet BioTherapeutics Holdings, Inc. Common Stock
stockNYSE

At CloseNov 20, 2026 2:36:04 PM EST
51.09USD+3954.762%(+49.83)1,283,905
Pre-marketNov 20, 2026 9:28:30 AM EST
50.80USD+3931.746%(+49.54)
After-hoursNov 20, 2026 4:00:30 PM EST
51.02USD-0.137%(-0.07)
Loading…
Loading…
348.88M
Healthcare
Biotechnology
HQ
Princeton, NJ, USA
Previous Close
$1.26
Beta
-986.57
52-Week High
$51.83 2026-11-20
52-Week Low
$1.26 2025-12-02
SMA 50
$5.52
SMA 200
$3.26
Avg. Vol 10D
1.75M
Avg. Vol 30D
1.10M
Avg. Vol 90D
979,945
Relative Vol
1.08
0.4100%
Sep 30, 2024 · 1-for-8 (reverse)
Oct 1, 2026
SONN Profile

sonnet biotherapeutics is an early stage company developing a pipeline of bifunctional therapies that attack immune-modulating targets to control cancer cells. sonnet biotherapeutics is utilizing a platform approach to develop a library of cancer-fighting immunotherapies. sonnet is based in cranbury, new jersey. sonnet mission: sonnet biotherapeutics is a platform enabled proof-of-concept engine created to generate immuno-oncology candidates and develop them into phase ii assets. we are leveraging a unique ip driven platform: ● single chain platform with pk enhancement ● selectively targeting tumors and their micro-environment ● validated targets only ● dual targeting can create synergies

SONN Performance
PeriodPriceDateChangeBeta
1W51.022026-11-20+0.16%0.000
6M1.262025-12-02+3955.56%0.000
1Y4.552025-11-21+1023.08%-986.574
2Y2.892024-11-21+1668.17%—
5Y1,438.982021-11-22-96.45%-14.751
SONN Stock Summary

Sonnet BioTherapeutics Holdings, Inc. Common Stock (NYSE:SONN) stock price today is $51.10, and today's volume is 1,183,907. SONN is up 3955.556% today. The 30 day average volume is 1.10M. SONN market cap is $348.88M with 6.83M shares outstanding.